Literature DB >> 12707936

Depression in Alzheimer's disease: the effect of serotonin receptor gene variation.

Clive Holmes1, Maria Arranz, David Collier, John Powell, Simon Lovestone.   

Abstract

This study investigated possible associations between selected polymorphisms in the serotonin receptor genes, 5-HT2A and 5-HT2C, with the presence of co-morbid depressive illness at baseline in a community based cohort of 158 patients with late onset patients with Alzheimer's disease (AD). An association was found between the presence of major depressive illness at baseline and both the 5-HT2A and 5-HT2C polymorphisms. Specifically, homozygous carriers of the 5-HT2A C102 allele were five times more likely to have major depressive illness than heterozygotes. In addition, homozygous or hemizygous carriers of the 5-HT2C Ser allele were 12 times more likely to have major depressive illness than homozygous or hemizygous carriers of the 5-HT2C Cys allele. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12707936     DOI: 10.1002/ajmg.b.10068

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  17 in total

Review 1.  Serotonergic system, cognition, and BPSD in Alzheimer's disease.

Authors:  Saikat Chakraborty; Jack C Lennon; Sridhar A Malkaram; Yan Zeng; Daniel W Fisher; Hongxin Dong
Journal:  Neurosci Lett       Date:  2019-04-01       Impact factor: 3.046

Review 2.  Psychiatric and behavioral symptoms in Alzheimer's disease and other dementias: etiology and management.

Authors:  Dag Aarsland; Sally Sharp; Clive Ballard
Journal:  Curr Neurol Neurosci Rep       Date:  2005-09       Impact factor: 5.081

Review 3.  The role of G protein-coupled receptors in the pathology of Alzheimer's disease.

Authors:  Amantha Thathiah; Bart De Strooper
Journal:  Nat Rev Neurosci       Date:  2011-02       Impact factor: 34.870

4.  Development and validation of a high-throughput screening method for two polymorphisms in the serotonin transporter gene.

Authors:  Moritz Eidens; Alexander Weise; Stefan Prause; Norbert Dahmen; Annette Wunsch; Mathias Max Weber; Thomas Forst; Andreas Pfützner
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

5.  Rates of depression in individuals with pathologic but not clinical Alzheimer disease are lower than those in individuals without the disease: findings from the Baltimore Longitudinal Study on Aging (BLSA).

Authors:  Melissa D Morgan; Michelle M Mielke; Richard O'Brien; Juan C Troncoso; Alan B Zonderman; Constantine G Lyketsos
Journal:  Alzheimer Dis Assoc Disord       Date:  2007 Jul-Sep       Impact factor: 2.703

6.  Prediction of psychosis onset in Alzheimer disease: the role of depression symptom severity and the HTR2A T102C polymorphism.

Authors:  Patricia A Wilkosz; Chowdari Kodavali; Elise A Weamer; Sachiko Miyahara; Oscar L Lopez; Vishwajit L Nimgaonkar; Steven T DeKosky; Robert A Sweet
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-12-05       Impact factor: 3.568

7.  Factors associated with a depressive disorder in Alzheimer's disease are different from those found for other dementia disorders.

Authors:  Maria Lage Barca; Knut Engedal; Jerson Laks; Geir Selbaek
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2012-02-03

8.  Behavioural genetics of Alzheimer's disease: a comprehensive review.

Authors:  Marcin Flirski; Tomasz Sobow; Iwona Kloszewska
Journal:  Arch Med Sci       Date:  2011-05-17       Impact factor: 3.318

9.  Serotonin 5-HT2A and 5-HT6 receptors in the prefrontal cortex of Alzheimer and normal aging patients.

Authors:  Dietrich E Lorke; Gang Lu; Eric Cho; David T Yew
Journal:  BMC Neurosci       Date:  2006-04-27       Impact factor: 3.288

10.  Candidate genes for antidepressant response to selective serotonin reuptake inhibitors.

Authors:  Francis E Lotrich; Bruce G Pollock
Journal:  Neuropsychiatr Dis Treat       Date:  2005-03       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.